AVBP
Price
$19.71
Change
+$0.69 (+3.63%)
Updated
Sep 12 closing price
Capitalization
799.61M
61 days until earnings call
RAPP
Price
$23.76
Change
+$0.56 (+2.41%)
Updated
Sep 12 closing price
Capitalization
1.1B
54 days until earnings call
Interact to see
Advertisement

AVBP vs RAPP

Header iconAVBP vs RAPP Comparison
Open Charts AVBP vs RAPPBanner chart's image
ArriVent BioPharma
Price$19.71
Change+$0.69 (+3.63%)
Volume$297.39K
Capitalization799.61M
Rapport Therapeutics
Price$23.76
Change+$0.56 (+2.41%)
Volume$1.67M
Capitalization1.1B
AVBP vs RAPP Comparison Chart in %
Loading...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVBP vs. RAPP commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (AVBP: $19.71 vs. RAPP: $23.76)
Brand notoriety: AVBP and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 105% vs. RAPP: 233%
Market capitalization -- AVBP: $799.61M vs. RAPP: $1.1B
AVBP [@Biotechnology] is valued at $799.61M. RAPP’s [@Biotechnology] market capitalization is $1.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • AVBP’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than AVBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 4 TA indicator(s) are bullish while RAPP’s TA Score has 6 bullish TA indicator(s).

  • AVBP’s TA Score: 4 bullish, 4 bearish.
  • RAPP’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RAPP is a better buy in the short-term than AVBP.

Price Growth

AVBP (@Biotechnology) experienced а -2.38% price change this week, while RAPP (@Biotechnology) price change was +65.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

AVBP is expected to report earnings on Nov 13, 2025.

RAPP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPP($1.1B) has a higher market cap than AVBP($800M). RAPP YTD gains are higher at: 33.935 vs. AVBP (-26.014). RAPP has higher annual earnings (EBITDA): -100.79M vs. AVBP (-148.33M). RAPP has more cash in the bank: 260M vs. AVBP (236M). AVBP has less debt than RAPP: AVBP (98K) vs RAPP (11.9M). AVBP (0) and RAPP (0) have equivalent revenues.
AVBPRAPPAVBP / RAPP
Capitalization800M1.1B73%
EBITDA-148.33M-100.79M147%
Gain YTD-26.01433.935-77%
P/E RatioN/A19.80-
Revenue00-
Total Cash236M260M91%
Total Debt98K11.9M1%
TECHNICAL ANALYSIS
Technical Analysis
AVBPRAPP
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIOUX57.490.08
+0.15%
Baron Opportunity R6
ADGCX17.22N/A
N/A
AB Core Opportunities C
SVIFX9.56N/A
N/A
Virtus Ceredex Large-Cap Value Equity C
JINTX34.37N/A
N/A
Johnson International
DCCIX31.90N/A
N/A
Macquarie Small Cap Core I

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with SYRE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
+3.63%
SYRE - AVBP
50%
Loosely correlated
-3.40%
CRNX - AVBP
45%
Loosely correlated
+0.80%
ELVN - AVBP
45%
Loosely correlated
+0.20%
IPSC - AVBP
44%
Loosely correlated
-3.38%
DNLI - AVBP
44%
Loosely correlated
-4.25%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with AVBP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then AVBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+2.41%
AVBP - RAPP
36%
Loosely correlated
+3.63%
PRAX - RAPP
35%
Loosely correlated
-4.35%
NUVB - RAPP
35%
Loosely correlated
-6.27%
FTRE - RAPP
35%
Loosely correlated
-1.27%
MLTX - RAPP
35%
Loosely correlated
-3.09%
More